Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis
- 1 June 1997
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 136 (6), 838-845
- https://doi.org/10.1111/j.1365-2133.1997.tb03922.x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Functional CD86 (B7-2/B70) on Cultured Human Langerhans CellsJournal of Investigative Dermatology, 1996
- TH2-Type Infiltrating T Cells in Nickel-Induced Contact DermatitisCellular Immunology, 1995
- Low‐dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co‐stimulatory molecules on human Langerhans cellsEuropean Journal of Immunology, 1995
- B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.The Journal of Experimental Medicine, 1994
- Expression of the B7/BB1 Activation Antigen and its Ligand CD28 in T-Cell-Mediated Skin DiseasesJournal of Investigative Dermatology, 1994
- Functional expression of B7/BB1 on activated T lymphocytes.The Journal of Experimental Medicine, 1993
- The Role of the CD28 Receptor During T Cell Responses To AntigensAnnual Review of Immunology, 1993
- House dust mite-specific T cells in the skin of subjects with atopic dermatitis: Frequency and lymphokine profile in the allergen patch testJournal of Allergy and Clinical Immunology, 1992
- Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathwayCellular Immunology, 1991
- The Mixed Epidermal Cell-Lymphocyte Reaction. II. Epidermal Langerhans Cells Are Responsible for the Enhanced Allogeneic Lymphocyte-Stimulating Capacity of Normal Human Epidermal Cell SuspensionsJournal of Investigative Dermatology, 1985